{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T00:15:54Z","timestamp":1714954554628},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ijcard.2024.132046","type":"journal-article","created":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T01:55:24Z","timestamp":1712973324000},"page":"132046","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anticoagulation in ACHD: The difficult journey toward evidences between analogy and incompleteness"],"prefix":"10.1016","volume":"406","author":[{"given":"Paolo","family":"Ferrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2024.132046_bb0005","first-page":"3","article-title":"Evidence based medicine: what it is and what it isn\u2019t. 1996","volume":"455","author":"Sackett","year":"2007","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.ijcard.2024.132046_bb0010","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: stroke prevention in atrial fibrillation II study","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2024.132046_bb0015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7326\/0003-4819-115-9-727","article-title":"Stroke prevention in nonvalvular atrial fibrillation","volume":"115","author":"Albers","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2024.132046_bb0020","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2024.132046_bb0025","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1093\/eurheartj\/ehaa844","article-title":"Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients","volume":"41","author":"Freisinger","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.132046_bb0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2019.06.014","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study","volume":"299","author":"Yang","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132046_bb0035","doi-asserted-by":"crossref","first-page":"131993","DOI":"10.1016\/j.ijcard.2024.131993","article-title":"Use of apixaban in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study","volume":"31","author":"Kartas","year":"2024","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324006429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324006429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T03:54:19Z","timestamp":1714881259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324006429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":7,"alternative-id":["S0167527324006429"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132046","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation in ACHD: The difficult journey toward evidences between analogy and incompleteness","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"132046"}}